Jan 11, 2024

JPI on antimicrobial resistance (AMR): Call 2024 launched!

JPIAMR has launched its international call 2024 for projects under the umbrella of JPIAMR and within the framework of the ERA-NET JPIAMR-ACTION. The call Interventions moving forward to promote action to counteract the emergence and spread of bacterial and fungal resistance and to improve treatments involves 21 funders from 19 countries. The total estimated call budget is over 19 million Euro.

To take action against the growing global threat of increased spread of antimicrobial (antibacterial and antifungal) resistance, this call will fund international collaborative research projects aiming to improve, compare and evaluate the effectiveness, cost effectiveness, and uptake of existing interventions against bacterial or fungal infections and/or to design new interventions against fungal infections.

Proposals should address one of the two topics of the call:

Topic 1: Design novel or improved interventions to prevent, mitigate and /or treat fungal infections, which are resistant to treatments and/or are at risk of developing resistance

The novel interventions for Topic 1 may include, but are not limited to: prevention strategies, treatments based on new or existing compounds or technologies, improved or novel diagnostics or surveillance

Topic 2: Improve and/or, compare and/or evaluate strategies, technologies, treatments, methods, protocols or data collection based on existing interventions, aiming to prevent or reduce the emergence or spread of antibacterial or antifungal resistance or to treat/cure infections caused by resistant bacteria/fungi and recommend new policies.

Within this topic, projects should address one or more of the following subtopics:

Improve and/or compare and/ or evaluate the effectiveness of existing interventions (e.g. cost effectiveness clinical utility, socio-economic adaptability, reducing AMR emergence, spread, transmission, treatment etc.)
Identify the barriers to uptake, including factors leading to the success or failure of previously run pilot interventions, and when applicable design solutions to overcome them.

The prevention and/or mitigation interventions for Topic 2 may include, but are not limited to:

Treatment (e.g. wastewater, medical, technological etc.),
protocols
Social, societal and behavioural intervention (e.g. public awareness campaigns, provider audit and feedback, reimbursement penalties, prescription requirements, infection prevention and control programmes),
Stewardship efforts (e.g. antimicrobial or vaccination guidelines).

These interventions may use technological, digital, or AI based approaches.

For all topics, reuse and/or improvement of the quality and sustainability of existing data is encouraged.

The following sub-topics are out of the scope of the call:

Antivirals and antiparasitics
Proposals solely aiming to treat plant or animal infections without link to human health
Proposals solely aiming to extend existing or implement new surveillance systems

Timeline and eligibility criteria:

14^th of March 2024 – pre-proposal submission
9^th of July 2024 – full-proposal submission
Funding for joint projects with min 3 partner from 3 participating countries
at least two partners must be EU Member States or Horizon Europe Associated Countries
maximum of six partners (7 und certain conditions)

Participating countries:

Australia, Belgium, Canada, France, Germany, Hungary, Ireland, Israel, Italy, Latvia, Lithuania, Moldova, The Netherlands, Norway, Poland, Spain, Sweden, Switzerland, United Kingdom